[1] 王莉,茅伟安,曹永兵,等. 28种药物联合氟康唑对白念珠菌体外抑菌作用的初步研究[J].中国真菌学杂志, 2013, 8(6):329-333.
[2] Gao L, Sun Y. In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms[J].Antimicrob Agents Chemother, 2015,59(11):7097-7099.
[3] Kubiça TF, Denardi LB, Azevedo MI, et al. Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates[J].Braz J Infect Dis,2016,20(6):539-545.
[4] Zhang J, Tan J, Yang L,et al. Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates[J].J Mycol Med,2018,28(4):612-616.
[5] 赵丽阳,李太杰,刘纯卉,等.他克莫司软膏联合二硫化硒洗剂治疗面部脂溢性皮炎的效果[J].实用临床医学,2020,21(3):20-22.
[6] 张琳. 0.03%他克莫司治疗面部激素依赖性皮炎的临床研究[J].中国实用医药,2020,15(5):159-161.
[7] Kumar A, Deshmukh K, Deora MS. The role of topical tacrolimus in adherence to antifungal therapy in recalcitrant tinea incognito:a preliminary non randomised controlled study[J].IJORD,2019,5(1):183.
[8] Juvvadi PR, Lee SC, Heitman J, et al. Calcineurin in fungal virulence and drug resistance:Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach[J].Virulence,2017,8(2):186-197.
[9] Zhang J, Silao FG, Bigol UG, et al. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae[J]. Plos one, 2012, 7(8):e44192.
[10] Thomas E, Sircaik S, Roman E, et al. The activity of RTA2, a downstream effector of the calcineurin pathway,is required during tunicamycin-induced ER stress response in Candida albicans[J]. FEMS Yeast Res,2015,15(8):fov095.
[11] Lee Y, Lee KT, Lee SJ, et al. In vitro and in vivo assessment of FK506 analogs as novel antifungal drug candidates[J].Antimicrob Agents Chemother,2018,62(11):e01627-18. |
